A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58

Journal of Antimicrobial Chemotherapy

Volumn 55, Issue 1, 2005, Pages 115-118

  Héritier, Claire ^a   Dubouix, Anne ^b   Poirel, Laurent ^a   Marty, Nicole ^b   Nordmann, Patrice ^a  

^a BICÊTRE HOSPITAL   (France)

^b CHU RANGUEIL   (France)

Author keywords

A. baumannii; Carbapenem resistance; Nosocomial infections

Indexed keywords

AMPICILLIN; AZTREONAM; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFPIROME; CEFTAZIDIME; COLISTIN; GENE PRODUCT; IMIPENEM; MEROPENEM; OXACILLINASE; PIPERACILLIN; PROTEIN OXA 58; RIFAMPICIN; SULBACTAM; TICARCILLIN; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; DNA FINGERPRINTING; DRUG HYDROLYSIS; EPIDEMIC; FRANCE; GENE EXPRESSION; GENE SEQUENCE; HOSPITAL INFECTION; HUMAN; INTEGRON; METHODOLOGY; MULTIDRUG RESISTANCE; NUCLEOTIDE SEQUENCE; PLASMID; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; SEQUENCE ANALYSIS; UNIVERSITY HOSPITAL;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; BETA-LACTAMASES; BURN UNITS; CARBAPENEMS; CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, BACTERIAL; FRANCE; HOSPITALS, UNIVERSITY; HUMANS; IMIPENEM; MICROBIAL SENSITIVITY TESTS; PLASMIDS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 13244269833     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh500     Document Type: Article

References (12)

1. Bergogne-Bérézin, E. & Towner, K. J. (1996). Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clinical Microbiology Reviews 9 148-65.
2. Poirel, L. & Nordmann, P. (2002). Acquired carbapenem-hydrolyzing β-lactamases and their genetic support. Current Pharmaceutical Biotechnology 3, 117-27.
3. Afzal-Shah, M., Woodford, N. & Livermore, D. M. (2001). Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy 45, 583-8.
4. Bou, G., Oliver, A. & Martinez-Beltran, J. (2000). OXA-24, a novel class D β-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain. Antimicrobial Agents and Chemotherapy 44, 1556-61.
5. Héritier, C., Poirel, L., Aubert, D. et al. (2003). Genetic and functional analysis of the chromosome-encoded carbapenem-hydrolyzing oxacillinase OXA-40 of Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy 47, 268-73.
6. Dalla-Costa, L. B., Coelho, J. M., Souza, H. A. et al. (2003). Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil. Journal of Clinical Microbiology 41, 3403-6.
7. Lopez-Otsoa, F., Gallego, L., Towner, K. J. et al. (2002). Endemic carbapenem resistance associated with OXA-40 carbapenemase among Acinetobacter baumannii isolates from a hospital in northern Spain. Journal of Clinical Microbiology 40 4741-3.
8. Poirel, L., Marqué, S., Héritier, C. et al. (2005). OXA-58, a novel β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy, in press.
9. National Committee for Clinical Laboratory Standards. (2003). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved Standard M7-A6. NCCLS, Wayne, PA, USA.
10. Kieser, T. (1984). Factors affecting the isolation of CCC DNA from Streptomyces lividans and Escherichia coli. Plasmid 12, 19-36.
11. Tenover, F. C., Arbeit, R. D., Goering, R. V. et al. (1995). Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. Journal of Clinical Microbiology 33, 2233-9.
12. Naas, T. & Nordmann, P. (1999). OXA-type β-lactamases. Current Pharmaceuticals Design 5, 865-79.